Erez Chimovits

Senior Managing Director at OrbiMed Advisors LLC

Erez Chimovits

Erez Chimovits

Senior Managing Director at OrbiMed Advisors LLC

Overview
Career Highlights

Compugen, Inc. /US
Therapix Biosciences Ltd.

RelSci Relationships

310

Number of Boards

13

Birthday

1964

Age

55

Relationships
RelSci Relationships are individuals Erez Chimovits likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founder at Adicet Bio, Inc.

Relationship likelihood: Strong

Senior Managing Director at OrbiMed Advisors LLC

Relationship likelihood: Strong

Chief Executive Officer at Novus Therapeutics, Inc.

Relationship likelihood: Strong

Co-Founder & Chief Executive Officer at Pontifax Management Co. Ltd.

Relationship likelihood: Strong

Co-Founder at Nucleix Ltd.

Relationship likelihood: Strong

Founder at AtoxBio, Inc.

Relationship likelihood: Strong

Chief Executive Officer at AtoxBio, Inc.

Relationship likelihood: Strong

Venture Partner at OrbiMed Advisors LLC

Relationship likelihood: Strong

Former Chief Executive Officer & Director at FutuRx Ltd.

Relationship likelihood: Strong

Chairman of the Board, Chief Executive Officer, Co-Founder at Nucleix Ltd.

Relationship likelihood: Strong

Paths to Erez Chimovits
Potential Connections via
Relationship Science
You
Erez Chimovits
Senior Managing Director at OrbiMed Advisors LLC
Education
M.Sc

Tel Aviv University (TAU) (Hebrew: ?????????? ???????? Universitat Tel Aviv) is a public university located in Ramat Aviv, Tel Aviv, Israel. With nearly 30,000 students, TAU is Israel's largest university. Located in Israel's cultural, financial and industrial core, Tel Aviv University is a major center of teaching and research, comprising 9 faculties, 27 schools, 98 departments and 128 research institutes and centers. Its origins go back to 1956, when three research institutes – the Tel Aviv School of Law and Economics, the Institute of Natural Sciences, and the Institute of Jewish Studies – joined together to form the University of Tel Aviv. Initially operated by the Tel Aviv municipality, the university was granted autonomy in 1963. The university also maintains academic supervision over the Center for Technological Design in Holon, the New Academic College of Tel Aviv-Yaffo, and the Afeka College of Engineering in Tel Aviv. The Wise Observatory is located in Mitzpe Ramon.

Career History
Senior Managing Director
Current

OrbiMed Advisors focuses on investments in the global healthcare industry. They utilizes strategies based on evaluating pharmaceutical, biotechnology, medical device, healthcare services and other companies in the global healthcare sector. The instruments in which OrbiMed invests include US and non-US equities, both long and short, as well as privately placed securities, debt securities, royalty bonds and other royalty instruments, currencies, private investments in public equity securities (PIPEs), ETFs, index options, and derivatives (including swap agreements). The firm invests across the global healthcare industry, from seed-stage venture capital to large publicly-traded companies. Investments are made across three strategies: public equity, private equity, and royalty opportunities. OrbiMed Advisors manages a series of public equity funds, including long/short event-driven funds and closed-end investment trusts. They invest across all types of publicly-traded companies, from biopharmaceuticals to medical devices and healthcare services worldwide. OrbiMed's private equity strategy is broad and flexible, investing from start-ups through growth equity. OrbiMed is typically a lead investor, seeking to help build our portfolio companies. Their geographic focus includes North America, Asia, Europe and Israel. For Royal Opportunities strategy, OrbiMed provides commercial-stage healthcare companies with non-dilutive structured debt capital. Additionally, they can monetize royalty streams, providing valuable financing solutions to owners of intellectual property.

Senior Managing Director
Current
Chief Executive Officer
2007 - Prior

Therapix Biosciences Ltd. is a specialty clinical-stage pharmaceutical company, focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. It initiated two internal drug development programs based on repurposing an FDA approved synthetic cannabinoid (dronabinol): Joint Pharma developing THX-TS01 targeted to the treatment of TS and BrainBright Pharma developing THX-ULD01 targeted to the high value and under-served market of MCIs. The company was founded on August 23, 2004 and is headquartered in Tel Aviv, Israel.

Boards & Committees
Chairman
Current

FutuRx Ltd. provides a unique model for supporting early stage innovation. The firm's global capabilities facilitate the development of innovative technologies, on the way to safely turning them into cutting-edge products for the benefit of patients and healthcare providers. The company was founded in January 2014 and is headquartered in Ness Ziona, Israel.

Director
Current

AtoxBio, Inc. provides novel immune modulators for critically ill patients with severe infections. The firm discovers and develops novel immune modulators for critically ill patients with severe infections. Its main product is AB103, a novel immune modulator. The company was founded by Raymond Kaempfer and Gila Arad in 2003 and is headquartered in Ness Ziona, Israel.

Member, Board of Directors
Current

cCAM Biotherapeutics Ltd. engages in the development of immunotherapies for different cancer indications. Its cCAM's lead agent, CM-24, is an immunomodulatory antibody that harnesses the patient's immune system to attack tumors. The company was founded in 2010 and is headquartered in Misgav, Israel.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Erez Chimovits. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Erez Chimovits's profile does not indicate a business or promotional relationship of any kind between RelSci and Erez Chimovits.